Pierluigi Nicotera
Overview
Explore the profile of Pierluigi Nicotera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
3443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wischhof L, Mathew A, Bonaguro L, Beyer M, Ehninger D, Nicotera P, et al.
Sci Rep
. 2024 Nov;
14(1):27182.
PMID: 39516523
Inhibition of the mitochondrial oxidative phosphorylation (OXPHOS) system can lead to metabolic disorders and neurodegenerative diseases. In primary mitochondrial disorders, reactive astrocytes often accompany neuronal degeneration and may contribute to...
2.
Scuteri D, Pierobon D, Pagliaro M, Hamamura K, Hayashi T, Pignolo L, et al.
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458585
Background: According to scientific literature, some 99% of patients affected by Alzheimer's disease (AD) suffer from behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms (NPSs). In...
3.
Wischhof L, Lee H, Tutas J, Overkott C, Tedt E, Stork M, et al.
EMBO J
. 2024 Sep;
43(19):4437-4438.
PMID: 39223333
No abstract available.
4.
Scuteri D, Pagliaro M, Mantia I, Contrada M, Pignolo L, Tonin P, et al.
Front Pharmacol
. 2024 Aug;
15:1417851.
PMID: 39148533
Background: An estimated 57.4 million people live with dementia worldwide, with the social burden of the disease steadily growing. Despite the approval of lecanemab and ongoing trials, there is still...
5.
Jackson J, Hoffmann C, Scifo E, Wang H, Wischhof L, Piazzesi A, et al.
Cell Death Dis
. 2024 May;
15(4):304.
PMID: 38693139
Abnormal intraneuronal accumulation of soluble and insoluble α-synuclein (α-Syn) is one of the main pathological hallmarks of synucleinopathies, such as Parkinson's disease (PD). It has been well documented that the...
6.
Corasaniti M, Bagetta G, Nicotera P, Maione S, Tonin P, Guida F, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38279266
The social burden of dementia is remarkable since it affects some 57.4 million people all over the world. Impairment of autophagy in age-related diseases, such as dementia, deserves deep investigation...
7.
Scuteri D, Pocobelli G, Sakurada Y, Russo R, Tonin P, Nicotera P, et al.
Biol Direct
. 2023 Oct;
18(1):66.
PMID: 37833756
The social impact of glaucoma is worth of note: primary open-angle glaucoma (POAG) is one of the leading causes of irreversible blindness worldwide, affecting some 68.56 million people with overall...
8.
Corasaniti M, Bagetta G, Nicotera P, Tarsitano A, Tonin P, Sandrini G, et al.
Toxins (Basel)
. 2023 May;
15(5).
PMID: 37235366
Some 14% of global prevalence, based on high-income country populations, suffers from migraine. Chronic migraine is very disabling, being characterized by at least 15 headache days per month of which...
9.
Wischhof L, Lee H, Tutas J, Overkott C, Tedt E, Stork M, et al.
EMBO J
. 2022 Oct;
41(23):e110595.
PMID: 36305367
Mammalian SWI/SNF/BAF chromatin remodeling complexes influence cell lineage determination. While the contribution of these complexes to neural progenitor cell (NPC) proliferation and differentiation has been reported, little is known about...
10.
Scuteri D, Tonin P, Nicotera P, Vulnera M, Altieri G, Tarsitano A, et al.
Toxins (Basel)
. 2022 Aug;
14(8).
PMID: 36006191
OnabotulinumtoxinA, targeting the CGRP machinery, has been approved for the last two decades for chronic migraine prevention. The recently approved monoclonal antibodies (mAbs) directed towards the calcitonin gene-related peptide (CGRP)...